Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid–enhanced MRI

[1]  M. Ronot,et al.  Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS , 2021, JHEP reports : innovation in hepatology.

[2]  J. Han,et al.  Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery. , 2021, Radiology.

[3]  Zhichao Feng,et al.  Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma. , 2021, Radiology.

[4]  Myeong-Jin Kim,et al.  Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications. , 2020, Journal of hepatology.

[5]  A. Luciani,et al.  Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma. , 2020, Radiology.

[6]  P. Kim,et al.  Arterial Subtraction Images of Gadoxetate-Enhanced MRI Improve Diagnosis of Early-Stage Hepatocellular Carcinoma. , 2019, Journal of hepatology.

[7]  A. Luciani,et al.  ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma , 2019, Clinical Cancer Research.

[8]  Young Kon Kim,et al.  Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System , 2018, Hepatology.

[9]  Myeong-Jin Kim,et al.  Hepatocellular Carcinoma with Irregular Rim-Like Arterial Phase Hyperenhancement: More Aggressive Pathologic Features , 2018, Liver Cancer.

[10]  A. Luciani,et al.  Macrotrabecular‐massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance , 2018, Hepatology.

[11]  C. Sirlin,et al.  Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis , 2018, Hepatology.

[12]  S. Imbeaud,et al.  Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. , 2017, Journal of hepatology.

[13]  Y. N. Park,et al.  Poor outcome of hepatocellular carcinoma with stemness marker under hypoxia: resistance to transarterial chemoembolization , 2016, Modern Pathology.

[14]  Bin Zhang,et al.  Clinicopathological indices to predict hepatocellular carcinoma molecular classification , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[15]  Yong Eun Chung,et al.  Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. , 2015, Radiology.

[16]  Myeong-Jin Kim,et al.  Added value of subtraction imaging in detecting arterial enhancement in small (<3 cm) hepatic nodules on dynamic contrast-enhanced MRI in patients at high risk of hepatocellular carcinoma , 2013, European Radiology.

[17]  Derek Y. Chiang,et al.  Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. , 2009, Cancer research.

[18]  Howard Y. Chang,et al.  Decoding global gene expression programs in liver cancer by noninvasive imaging , 2007, Nature Biotechnology.

[19]  S. Boyault,et al.  Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets , 2007, Hepatology.